Welcome to our dedicated page for SYNAPTICS SEC filings (Ticker: SYNA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Synaptics Incorporated filings document results reporting, governance changes, capital-structure actions and proxy disclosures for the semiconductor company. Form 8-K reports furnish quarterly and annual operating results, supplemental earnings materials and related GAAP and non-GAAP measures tied to revenue, margins, expenses and per-share results.
Other filings cover board-approved share repurchase authorization, amendments to bylaws, universal-proxy and advance-notice provisions, remote meeting mechanics, uncertificated shares and an exclusive-forum provision under Delaware corporate law. The definitive proxy statement documents shareholder voting matters, director elections, executive compensation, equity awards and pay-versus-performance disclosures.
Synaptics Incorporated furnished an update on operations by announcing results for the fiscal quarter ended September 27, 2025. The company issued a press release and posted supplemental earnings materials on its investor website.
The press release is included as Exhibit 99.1 and is furnished under Item 2.02, which means it is not deemed filed under Section 18 of the Exchange Act nor incorporated by reference into other filings.
Synaptics (SYNA) disclosed a Form 4 showing a director acquired 3,036 shares of common stock at $0 on November 3, 2025, increasing direct beneficial ownership to 25,226 shares. The filing notes these were restricted stock units (RSUs) that vest quarterly, with full vesting on November 3, 2026, or, for a director not standing for re‑election, on the date of the company’s 2026 Annual Meeting of Stockholders.
Synaptics Inc. (SYNA) disclosed a director equity transaction on Form 4. On 11/03/2025, the director acquired 3,036 shares of common stock at $0 per share under an equity award, bringing total directly held shares to 10,958.
The award reflects restricted stock units (RSUs) that vest in quarterly installments, with full vesting by November 3, 2026, or for a director not standing for re-election, on the date of the company’s 2026 Annual Meeting of Stockholders. No derivative securities were reported in Table II.
Synaptics (SYNA) disclosed a Form 4 showing a director acquired 3,036 shares of common stock on 11/03/2025 from a restricted stock unit grant at a stated price of $0. Following the transaction, the director beneficially owns 40,977 shares directly.
The award vests in equal quarterly installments, with one-fourth of the RSUs vesting each quarter until fully vested on November 3, 2026, or, for a director not standing for re-election, on the date of the company’s 2026 Annual Meeting of Stockholders. This reflects routine director equity compensation and a time-based vesting schedule.
Synaptics, Inc. (SYNA) disclosed an insider transaction on a Form 4. A company director acquired 3,036 shares of common stock on 11/03/2025 at a price of $0, increasing direct beneficial ownership to 21,657 shares.
The acquisition reflects vesting of restricted stock units (RSUs), which are scheduled to vest quarterly until fully vested on November 3, 2026, or, for a director not standing for re‑election, on the date of the Issuer’s 2026 Annual Meeting of Stockholders.
Synaptics (SYNA) director reported an equity grant. On 11/03/2025, a director acquired 3,036 shares of common stock for $0, reflected as a restricted stock unit award. Following the transaction, the director beneficially owned 14,334 shares, held directly.
The award vests in equal quarterly installments, with one-fourth vesting each quarter until fully vested on November 3, 2026, or, for a director not standing for re‑election, on the date of the company’s 2026 Annual Meeting of Stockholders.
Synaptics (SYNA) disclosed that a director acquired 3,036 shares of common stock on 11/03/2025 at $0 under a Code A transaction, increasing direct holdings to 11,838 shares.
The award is tied to restricted stock units that vest quarterly until fully vested on November 3, 2026, or, if the director does not stand for re-election, on the date of the 2026 Annual Meeting of Stockholders.
Synaptics (SYNA) Form 4: A company director reported an award of 3,036 shares of common stock on 11/03/2025 at a reported price of $0, reflecting a restricted stock unit grant. Following this transaction, the director beneficially owned 45,719 shares, held directly.
The award vests in equal quarterly installments, with one-fourth of the RSUs vesting each quarter until fully vested on November 3, 2026, or, for a director not standing for re-election, on the date of the company’s 2026 Annual Meeting of Stockholders.
Synaptics Incorporated reported final voting results from its 2025 Annual Meeting. Stockholders approved amendments to two equity programs, adding 1,900,000 shares to the Amended and Restated 2019 Equity and Incentive Compensation Plan and 1,500,000 shares to the Amended and Restated 2019 Employee Stock Purchase Plan.
Six directors were elected to serve until the 2026 meeting, the appointment of KPMG LLP as independent auditor was ratified, and stockholders approved the non-binding advisory vote on executive compensation. As of the September 4, 2025 record date, 39,050,213 shares were outstanding and entitled to vote; 36,497,062 shares (93.46%) were present at the meeting.
Esther Song, Vice President and Corporate Controller of Synaptics Inc (SYNA), reported a Form 4 disclosing a transaction on 09/17/2025. The filing shows 302 shares of common stock were disposed (code F) at a price of $71.91. Following the reported transaction, the filing lists 22,288 shares beneficially owned by the reporting person; that total includes 223 shares acquired under the company Employee Stock Purchase Plan on September 15, 2025. The form notes the 302 shares were withheld by the issuer to satisfy tax withholding on restricted stock unit vesting. The form is signed on behalf of the reporting person by Pamela Fields, attorney-in-fact, dated 09/18/2025.